Statement Summary
On May 21, 2025, the SEC charged Jeremy Jordan-Jones, CEO of Amalgam Capital Ventures LLC, with offering fraud for making false claims to secure a $500,000 investment from a venture capital firm. Between November 2021 and February 2022, he allegedly misrepresented the readiness of a blockchain-based payment platform, mischaracterized the company’s financial health, and fabricated partnerships that would generate revenue. Contrary to his claims, Amalgam lacked the necessary infrastructure and even had a negative bank balance. Instead of using the investment to build the company, Jordan-Jones diverted at least $111,000 for personal expenses. The SEC seeks various penalties against him, including a permanent injunction and an officer-and-director bar. Additionally, the U.S. Attorney’s Office has filed parallel criminal charges.
Original Statement
Jeremy Jordan-Jones
U.S. SECURITIES AND EXCHANGE COMMISSION
Litigation Release No. 26309 / May 22, 2025
Securities and Exchange Commission v. Jeremy Jordan-Jones, No. 1:25-cv-04297 (S.D.N.Y. filed May 21, 2025)
SEC Charges Founder and CEO of Start-Up Technology Company with Offering Fraud
On May 21, 2025, the Securities and Exchange Commission charged Jeremy Jordan-Jones, the CEO of Amalgam Capital Ventures LLC, a start-up technology company purportedly based in New York, with making material misrepresentations to convince a venture capital firm to invest $500,000 with Amalgam.
According to the complaint, between November 2021 and February 2022, Jordan-Jones solicited the venture capital firm by making material misrepresentations in a product deck and due diligence report, including that Amalgam had developed a blockchain-based point-of-sale payment and processing platform that would be ready to launch commercially after Amalgam acquired approximately $350,000 for infrastructure purposes.
According to the complaint, Jordan-Jones also misrepresented the company’s financial condition, as well as the existence of certain professional partnerships with other organizations that would generate revenue for Amalgam. However, as alleged in the complaint, in reality, Amalgam did not possess the necessary technical capabilities or infrastructure to launch the platform, Amalgam had not entered any contracts that would generate revenues, and Amalgam’s bank account had a negative balance. The complaint further alleges, upon receiving the investor’s funds, Jordan-Jones failed to acquire the purportedly necessary infrastructure, and instead used the funds for other purposes, including to pay at least $111,000 in personal expenses.
The complaint, filed in the U.S. District Court for the Southern District of New York, charges Jordan-Jones with violating Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The SEC seeks permanent injunctions, disgorgement plus prejudgment interest, a civil penalty, and an officer-and-director bar.
In a parallel action, the U.S Attorney’s Office for the Southern District of New York filed criminal charges against Jordan-Jones.
The SEC’s ongoing investigation is being conducted by Mao Yu Lin, Elizabeth Butler, and James Flynn, under the supervision of Sandeep Satwalekar and Thomas P. Smith, Jr., all of the New York Regional Office. The litigation will be led by Travis Hill and supervised by Jack Kaufman, also of the New York Regional Office.
